HMGCR and cancer: Statins are inhibitors of HMG-CoA reductase (HMGCR), the rate-limiting enzyme in the mevalonate pathway responsible for cholesterol biosynthesis (Patel et al., 2022), have demonstrated promising therapeutic effects against various cancers.